 |
(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate |
|---|---|
| Trade Name | |
| Orphan Indication | Soft tissue sarcoma |
| EU Market Approval | EU |
| EU Designation Date | 2016-01-11 00:00:00 |
| Sponsor | Loxo Oncology Limited |
